Clinical pharmacokinetics

Keyphrases

Publications

volume 62, number 1, 2023

Megan Melch, Jongtae Lee, Claudia Jomphe, Gabriel J Robbie
Population Pharmacokinetic Analysis of the RNAi Therapeutic Givosiran in Patients with Acute Hepatic Porphyria. Clinical pharmacokinetics 62 (1) (2023)
Félicien Le Louedec, Florent Puisset, Étienne Chatelut, Michel Tod
Considering the Oral Bioavailability of Protein Kinase Inhibitors: Essential in Assessing the Extent of Drug-Drug Interaction and Improving Clinical Practice. Clinical pharmacokinetics 62 (1) (2023)
Félicien Le Louedec, Florent Puisset, Étienne Chatelut, Michel Tod
Considering the Oral Bioavailability of Protein Kinase Inhibitors: Essential in Assessing the Extent of Drug-Drug Interaction and Improving Clinical Practice. Clinical pharmacokinetics 62 (1) (2023)
Bernard Royer, Courèche Guillaume Kaderbhaï, Antonin Schmitt
Pharmacokinetics and Pharmacodynamic of Alpelisib. Clinical pharmacokinetics 62 (1) (2023)
Marion Hemmersbach-Miller, Stephen J Balevic, Patricia L Winokur, Cornelia B Landersdorfer, Kenan Gu, Austin W Chan, Michael Cohen-Wolkowiez, Thomas Conrad, Guohua An, Carl M J Kirkpatrick, Geeta K Swamy, Emmanuel B Walter, Kenneth E Schmader
Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan. Clinical pharmacokinetics 62 (1) (2023)
Félicien Le Louedec, Florent Puisset, Étienne Chatelut, Michel Tod
Considering the Oral Bioavailability of Protein Kinase Inhibitors: Essential in Assessing the Extent of Drug-Drug Interaction and Improving Clinical Practice. Clinical pharmacokinetics 62 (1) (2023)
Megan Melch, Jongtae Lee, Claudia Jomphe, Gabriel J Robbie
Population Pharmacokinetic Analysis of the RNAi Therapeutic Givosiran in Patients with Acute Hepatic Porphyria. Clinical pharmacokinetics 62 (1) (2023)
Birte Maria Hofmann, Manja Ahola, Lueder M Fels, Stefan Klein, Bernhard Lindenthal, Jyrki Pihlaja
Development of an Intrauterine Device Releasing Both Indomethacin and Levonorgestrel During the First Months of Use: Pharmacokinetic Characterization in Healthy Women. Clinical pharmacokinetics 62 (1) (2023)
Bernard Royer, Courèche Guillaume Kaderbhaï, Antonin Schmitt
Pharmacokinetics and Pharmacodynamic of Alpelisib. Clinical pharmacokinetics 62 (1) (2023)
Megan Melch, Jongtae Lee, Claudia Jomphe, Gabriel J Robbie
Population Pharmacokinetic Analysis of the RNAi Therapeutic Givosiran in Patients with Acute Hepatic Porphyria. Clinical pharmacokinetics 62 (1) (2023)
Bernard Royer, Courèche Guillaume Kaderbhaï, Antonin Schmitt
Pharmacokinetics and Pharmacodynamic of Alpelisib. Clinical pharmacokinetics 62 (1) (2023)
Félicien Le Louedec, Florent Puisset, Étienne Chatelut, Michel Tod
Considering the Oral Bioavailability of Protein Kinase Inhibitors: Essential in Assessing the Extent of Drug-Drug Interaction and Improving Clinical Practice. Clinical pharmacokinetics 62 (1) (2023)
Megan Melch, Jongtae Lee, Claudia Jomphe, Gabriel J Robbie
Population Pharmacokinetic Analysis of the RNAi Therapeutic Givosiran in Patients with Acute Hepatic Porphyria. Clinical pharmacokinetics 62 (1) (2023)
Jeroen Vervalcke, Arnaud De Clercq, Peter De Paepe, Mirko Petrovic, Tania Desmet, Pieter A De Cock
Pharmacokinetics and Target Attainment of ß-lactam Antibiotics in Older People: A Systematic Review of Current Literature. Clinical pharmacokinetics 62 (1) (2023)
Jeroen Vervalcke, Arnaud De Clercq, Peter De Paepe, Mirko Petrovic, Tania Desmet, Pieter A De Cock
Pharmacokinetics and Target Attainment of ß-lactam Antibiotics in Older People: A Systematic Review of Current Literature. Clinical pharmacokinetics 62 (1) (2023)
Jeroen Vervalcke, Arnaud De Clercq, Peter De Paepe, Mirko Petrovic, Tania Desmet, Pieter A De Cock
Pharmacokinetics and Target Attainment of ß-lactam Antibiotics in Older People: A Systematic Review of Current Literature. Clinical pharmacokinetics 62 (1) (2023)
Bernard Royer, Courèche Guillaume Kaderbhaï, Antonin Schmitt
Pharmacokinetics and Pharmacodynamic of Alpelisib. Clinical pharmacokinetics 62 (1) (2023)
Birte Maria Hofmann, Manja Ahola, Lueder M Fels, Stefan Klein, Bernhard Lindenthal, Jyrki Pihlaja
Development of an Intrauterine Device Releasing Both Indomethacin and Levonorgestrel During the First Months of Use: Pharmacokinetic Characterization in Healthy Women. Clinical pharmacokinetics 62 (1) (2023)
Marion Hemmersbach-Miller, Stephen J Balevic, Patricia L Winokur, Cornelia B Landersdorfer, Kenan Gu, Austin W Chan, Michael Cohen-Wolkowiez, Thomas Conrad, Guohua An, Carl M J Kirkpatrick, Geeta K Swamy, Emmanuel B Walter, Kenneth E Schmader
Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan. Clinical pharmacokinetics 62 (1) (2023)
Birte Maria Hofmann, Manja Ahola, Lueder M Fels, Stefan Klein, Bernhard Lindenthal, Jyrki Pihlaja
Development of an Intrauterine Device Releasing Both Indomethacin and Levonorgestrel During the First Months of Use: Pharmacokinetic Characterization in Healthy Women. Clinical pharmacokinetics 62 (1) (2023)
Marion Hemmersbach-Miller, Stephen J Balevic, Patricia L Winokur, Cornelia B Landersdorfer, Kenan Gu, Austin W Chan, Michael Cohen-Wolkowiez, Thomas Conrad, Guohua An, Carl M J Kirkpatrick, Geeta K Swamy, Emmanuel B Walter, Kenneth E Schmader
Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan. Clinical pharmacokinetics 62 (1) (2023)
Marion Hemmersbach-Miller, Stephen J Balevic, Patricia L Winokur, Cornelia B Landersdorfer, Kenan Gu, Austin W Chan, Michael Cohen-Wolkowiez, Thomas Conrad, Guohua An, Carl M J Kirkpatrick, Geeta K Swamy, Emmanuel B Walter, Kenneth E Schmader
Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan. Clinical pharmacokinetics 62 (1) (2023)
Birte Maria Hofmann, Manja Ahola, Lueder M Fels, Stefan Klein, Bernhard Lindenthal, Jyrki Pihlaja
Development of an Intrauterine Device Releasing Both Indomethacin and Levonorgestrel During the First Months of Use: Pharmacokinetic Characterization in Healthy Women. Clinical pharmacokinetics 62 (1) (2023)
Marion Hemmersbach-Miller, Stephen J Balevic, Patricia L Winokur, Cornelia B Landersdorfer, Kenan Gu, Austin W Chan, Michael Cohen-Wolkowiez, Thomas Conrad, Guohua An, Carl M J Kirkpatrick, Geeta K Swamy, Emmanuel B Walter, Kenneth E Schmader
Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan. Clinical pharmacokinetics 62 (1) (2023)

volume 62, number 2, 2023

Diana Morales Castro, Linda Dresser, John Granton, Eddy Fan
Pharmacokinetic Alterations Associated with Critical Illness. Clinical pharmacokinetics 62 (2) (2023)
Pierre Bourgoin, Jules Lecomte, Mehdi Oualha, Lionel Berthomieu, Tony Pereira, Emeline Davril, Fabien Lamoureux, Nicolas Joram, Alexis Chenouard, Thomas Duflot
Population Pharmacokinetics of Levosimendan and its Metabolites in Critically Ill Neonates and Children Supported or Not by Extracorporeal Membrane Oxygenation. Clinical pharmacokinetics 62 (2) (2023)
Yan Rong, Tony K L Kiang
Clinical Evidence on the Purported Pharmacokinetic Interactions between Corticosteroids and Mycophenolic Acid. Clinical pharmacokinetics 62 (2) (2023)
Vianney Tuloup, Sylvain Goutelle, Michel Tod, Laurent Bourguignon
Evaluation of Renal Impairment Influence on Metabolic Drug Clearance using a Modelling Approach. Clinical pharmacokinetics 62 (2) (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics 62 (2) (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics 62 (2) (2023)
M R Hesse, J R Prins, M N Lub-de Hooge, H L J Winter, J G W Kosterink, D J Touw, Paola Mian
Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I-Penicillins. Clinical pharmacokinetics 62 (2) (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics 62 (2) (2023)
Yan Rong, Tony K L Kiang
Clinical Evidence on the Purported Pharmacokinetic Interactions between Corticosteroids and Mycophenolic Acid. Clinical pharmacokinetics 62 (2) (2023)
M R Hesse, J R Prins, M N Lub-de Hooge, H L J Winter, J G W Kosterink, D J Touw, Paola Mian
Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I-Penicillins. Clinical pharmacokinetics 62 (2) (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics 62 (2) (2023)
Vianney Tuloup, Sylvain Goutelle, Michel Tod, Laurent Bourguignon
Evaluation of Renal Impairment Influence on Metabolic Drug Clearance using a Modelling Approach. Clinical pharmacokinetics 62 (2) (2023)
M R Hesse, J R Prins, M N Lub-de Hooge, H L J Winter, J G W Kosterink, D J Touw, Paola Mian
Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I-Penicillins. Clinical pharmacokinetics 62 (2) (2023)
Diana Morales Castro, Linda Dresser, John Granton, Eddy Fan
Pharmacokinetic Alterations Associated with Critical Illness. Clinical pharmacokinetics 62 (2) (2023)
M R Hesse, J R Prins, M N Lub-de Hooge, H L J Winter, J G W Kosterink, D J Touw, Paola Mian
Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I-Penicillins. Clinical pharmacokinetics 62 (2) (2023)
Pierre Bourgoin, Jules Lecomte, Mehdi Oualha, Lionel Berthomieu, Tony Pereira, Emeline Davril, Fabien Lamoureux, Nicolas Joram, Alexis Chenouard, Thomas Duflot
Population Pharmacokinetics of Levosimendan and its Metabolites in Critically Ill Neonates and Children Supported or Not by Extracorporeal Membrane Oxygenation. Clinical pharmacokinetics 62 (2) (2023)

volume 62, number 5, 2023

Emaad Abdel-Kahaar, Frieder Keller
Clinical Pharmacokinetics and Pharmacodynamics of Voclosporin. Clinical pharmacokinetics 62 (5) (2023)
Luis Ortega-Paz, Salvatore Giordano, Francesco Franchi, Fabiana Rollini, Charles V Pollack, Deepak L Bhatt, Dominick J Angiolillo
Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of Bentracimab. Clinical pharmacokinetics 62 (5) (2023)
Emaad Abdel-Kahaar, Frieder Keller
Clinical Pharmacokinetics and Pharmacodynamics of Voclosporin. Clinical pharmacokinetics 62 (5) (2023)
Luis Ortega-Paz, Salvatore Giordano, Francesco Franchi, Fabiana Rollini, Charles V Pollack, Deepak L Bhatt, Dominick J Angiolillo
Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of Bentracimab. Clinical pharmacokinetics 62 (5) (2023)
Luis Ortega-Paz, Salvatore Giordano, Francesco Franchi, Fabiana Rollini, Charles V Pollack, Deepak L Bhatt, Dominick J Angiolillo
Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of Bentracimab. Clinical pharmacokinetics 62 (5) (2023)
Weifeng Tang, Raj Tummala, Joachim Almquist, Michael Hwang, Wendy I White, David W Boulton, Alexander MacDonald
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab. Clinical pharmacokinetics 62 (5) (2023)
Weifeng Tang, Raj Tummala, Joachim Almquist, Michael Hwang, Wendy I White, David W Boulton, Alexander MacDonald
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab. Clinical pharmacokinetics 62 (5) (2023)
Luis Ortega-Paz, Salvatore Giordano, Francesco Franchi, Fabiana Rollini, Charles V Pollack, Deepak L Bhatt, Dominick J Angiolillo
Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of Bentracimab. Clinical pharmacokinetics 62 (5) (2023)
Weifeng Tang, Raj Tummala, Joachim Almquist, Michael Hwang, Wendy I White, David W Boulton, Alexander MacDonald
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab. Clinical pharmacokinetics 62 (5) (2023)
Emaad Abdel-Kahaar, Frieder Keller
Clinical Pharmacokinetics and Pharmacodynamics of Voclosporin. Clinical pharmacokinetics 62 (5) (2023)